• The emerging role of helicobacter pylori-induced metabolic gastrointestinal dysmotility and neurodegeneration 

      Kountouras J., Boziki M., Polyzos S.A., Katsinelos P., Gavalas E., Zeglinas C., Tzivras D., Romiopoulos I., Giorgakis N., Anastasiadou K., Vardaka E., Kountouras C., Kazakos E., Giartza-Taxidou E., Deretzi G., Dardiotis E., Kotronis G., Doulberis M. (2017)
      Helicobacter pylori infection (Hp-I) is a prevalent disorder identified in themajority of the population in many countries around the world and is responsible for substantial gastrointestinal morbidity. Likewise, ...
    • Urinary Metabolomics From a Dose-Fractionated Polymyxin B Rat Model of Acute Kidney Injury 

      Locci E., Liu J., Pais G.M., Chighine A., Kahnamoei D.A., Xanthos T., Chalkias A., Lee A., Hauser A.R., Chang J., Rhodes N.J., d'Aloja E., Scheetz M.H. (2022)
      Background: Polymyxin B treatment is limited by kidney injury. This study sought to identify Polymyxin B-related urinary metabolomic profile modifications for early detection of polymyxin-associated nephrotoxicity. Methods: ...